Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.28 -0.05 (-3.76%)
At close: Sep 29, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Operating Expenses (2013 - 2026)

Updated

Tvardi Therapeutics' Operating Expenses came in at $6.63 million for Q2 2026, down 25.3% from $8.87 million a year earlier and down 6.0% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Operating Expenses (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Tvardi Therapeutics reported Operating Expenses of $27.21 million, down 8.4% year-over-year; for FY2025, it was $26.75 million, down 4.8% from FY2024.

  • Operating Expenses carries a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $28.11 million in FY2024 (-80.3%), $142.46 million in FY2023 (+10.1%), $129.4 million in FY2022 (+15.4%) and $112.11 million in FY2021 (-13.6%).
  • The five-year range for quarterly Operating Expenses is $4.35 million (Q1 2025) to $39.27 million (Q2 2023).
  • Year-over-year, Operating Expenses increased in three of the last eight quarters, with an average decline of 25.5%.
  • The fastest year-over-year change in Operating Expenses over five years came in Q3 2022 (growth of 62.0%), and the weakest in Q1 2025 (a decline of 86.3%).
  • Business Quant data shows TVRD's Operating Expenses at $7.05 million (Q1 2026), $7.59 million (Q4 2025) and $5.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Tvardi Therapeutics 12.48 Mn 12.48 Mn - 6.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.63 Mn
Mar 31, 2026 7.05 Mn
Dec 31, 2025 7.59 Mn
Sep 30, 2025 5.94 Mn
Jun 30, 2025 8.87 Mn
Mar 31, 2025 4.35 Mn
Dec 31, 2024 10.80 Mn
Sep 30, 2024 5.68 Mn
Jun 30, 2024 7.18 Mn
Mar 31, 2024 31.80 Mn
Dec 31, 2023 35.61 Mn
Sep 30, 2023 33.76 Mn
Jun 30, 2023 39.27 Mn
Mar 31, 2023 33.82 Mn
Dec 31, 2022 34.57 Mn
Sep 30, 2022 34.66 Mn
Jun 30, 2022 27.48 Mn
Mar 31, 2022 32.70 Mn
Dec 31, 2021 34.34 Mn
Sep 30, 2021 21.40 Mn
API Access

Tvardi Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TVRD&period=max&api_key=YOUR_API_KEY